Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Acceptability of a Rapid Assessment of Esophageal Adenocarcinoma Risk Test (REACT)

NCT03366012 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT03366012
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03366012 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Acceptability of a Rapid Assessment of Esophageal Adenocarcinoma Risk Test (REACT)
Lead sponsor
Columbia University
Phase
Not applicable
Overall status
Terminated
Start date
August 1, 2018
Completion date
May 19, 2023
Enrollment
51 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

barrett esophagus, esophageal adenocarcinoma